PharmacyCodes



Kenalog in Orabase en es it fr

Categoria

Kenalog in Orabase Nombres de marca, Kenalog in Orabase Analogos

Kenalog in Orabase Marca los nombres de mezcla

  • Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide)
  • Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide)
  • Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide)
  • Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
  • Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)

    • Kenalog in Orabase Formula quimica

    C21H27FO6

    Kenalog in Orabase RX enlace

    http://www.rxlist.com/cgi/generic/triamaer.htm

    Kenalog in Orabase FDA hoja

    Kenalog_in_Orabase FDA

    Kenalog in Orabase MSDS (hoja de seguridad de materiales)

    Kenalog_in_Orabase MSDS

    Kenalog in Orabase Sintesis de referencia

    Fried et al., J. Am. Chem. .. Soc. 80, 2338 (1958)

    Kenalog in Orabase Peso molecular

    394.434 g/mol

    Kenalog in Orabase Punto de fusion

    274 - 278 (dec) oC

    Kenalog in Orabase H2O Solubilidad

    80 mg / L

    Kenalog in Orabase Estado

    Solid

    Kenalog in Orabase LogP

    0.329

    Kenalog in Orabase Formas de dosificacion

    Crema, líquido, los inhaladores de dosis (aerosol), ungüento, pasta, suspensión, jarabe, Tablet

    Kenalog in Orabase Indicacion

    Para el tratamiento de la rinitis alérgica perenne y estacional.

    Kenalog in Orabase Farmacologia

    Triamcinolona y sus derivados son glucocorticoides sintéticos que se utilizan por sus propiedades antiinflamatorias o inmunosupresoras.

    Kenalog in Orabase Absorcion

    Rápida absorción tras la administración oral

    Kenalog in Orabase Toxicidad

    LD50 => 500mg/kg (en ratas)

    Kenalog in Orabase Informacion de Pacientes

    Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions. This information is intended to aid them in the safe and effective use of this medication. It is not a complete disclosure of all possible adverse or intended effects.

    Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2 weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do not improve or if the condition worsens.

    In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.

    Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister after 240 actuations since reliable dose delivery cannot be assured after 240 doses.

    Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles and if exposed, to obtain medical advice.

    Kenalog in Orabase Organismos afectados

    Humanos y otros mamíferos